Read article – Cody Meissner, a professor of pediatrics, has been named by Health and Human Services Secretary Robert F. Kennedy Jr. as one of the eight new members on a government panel of vaccine advisers. (Similar coverage in Yahoo! News.)

Read article – Nicholas Jacobson, an associate professor of biomedical data science and psychiatry, is quoted in a story about the clinical trial results for Dartmouth’s therapy chatbot, Therabot, and the efficacy of AI-powered mental health care. “Participants felt like they could let their guards down. They know they’re not going to be judged,” Jacobson said.

Listen here – Mitch Zeller, senior associate dean of clinical and translational research, is featured on an episode of In Good Health to discuss vaping regulations. “You can’t just abolish two entire offices in a center that is ordered by Congress to regulate the single most harmful, deadly, and dangerous consumer product and expect there not to be public health ramifications,” Zeller said. (Zeller’s comments begin at approximately 5:30.)

Listen now – Thom Walsh, adjunct instructor in The Dartmouth Institute, is featured on episode 734 of The Attitude with Arnie Arnesen podcast, discussing the proposed work requirements for Medicaid recipients.

Read article – Features a project co-created by Megan Romano, an associate professor of epidemiology, known as PFAS Understanding in Local Schools and Environments, or PULSE. The study will examine the effects of PFAS “forever chemicals” found in drinking water.

Read article – Alex Conway ’20, MED ’25, is featured in an article about a video she posted related to the health effects of methane emissions from gas stove tops.”I think it’s important that people know about the health effects of methane gas because it’s something we can change,” Conway said.

Read article – Nicholas Jacobson, an associate professor of biomedical data science and psychiatry, is quoted in a story about an American Psychological Association health advisory on AI and adolescents. “This is a new technology that is probably potentially as big in terms of its impact on human development as the internet,” Jacobson said.

Read article – Nicholas Jacobson, an associate professor of biomedical data science and psychiatry, talks about the risks of commercial therapy chatbots in the context of Therabot, the first AI therapy chatbot to undergo a clinical trial. “A lot of folks in Silicon Valley want to move fast and break things, but in this case, they’re not breaking things—they’re breaking people,” Jacobson said.

Read article – Zbigniew M. Szczepiorkowski, a professor of pathology and laboratory medicine, is cited as a third-party expert in an article about the first trials on plasma exchange for anti-aging in humans. Szczepiorkowski notes that it’s not clear if the findings were a direct result of the treatment or if they were influenced by some other confounding factor.